Clover Health (NASDAQ:CLOV) stock is moving higher Wednesday after the company's subsidiary, Counterpart Health, announced a multi-year agreement with Iowa Clinic.
What To Know: Under the agreement, clinicians serving The Iowa Clinic's Medicare Advantage and Medicare Shared Savings Program patients will use Counterpart Assistant.
This technology will also be available to The Iowa Clinic's clinically integrated network partners throughout the Midwest. Counterpart Assistant is An AI-driven solution created to integrate into physicians' workflows, facilitating earlier diagnosis and management of chronic diseases.
CEO of The Iowa Clinic Ben Vallier said, "Counterpart's ability to harness clinical data to drive improved outcomes, combined with its intuitive design that understands the needs of practicing clinicians, stood out among other potential solutions, and makes it a perfect fit for our organization. We are very optimistic about the immediate and long-term clinical and financial value it will bring to our providers and patients alike."
Counterpart Health will receive a per-member, per-month fee, along with possible incentive payments tied to meeting certain care management objectives.
CLOV Price Action: At the time of publication, Clover Health shares are moving 14.6% higher at $2.86 per data from Benzinga Pro.